Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (8): 921-924.
DOI: 10.19803/j.1672-8629.20230795

Previous Articles     Next Articles

560 cases of adverse drug reaction/event caused by Mailu Shutong pills

WANG Yuxi1, ZHANG Zonglin1, WANG Yingli1, CHEN Yafei2, LI Junsheng1, HUO Yanfei3, XIE Yanjun3#, LIU Wenqi1,*   

  1. 1Department of Pharmacy, Linyi People’s Hospital, Linyi Shandong 276000, China;
    2Linyi Pharmacovigilance Center, Linyi Shandong 276000, China;
    3Shandong Adverse Drug Reaction Monitoring Center, Jina Shandong 250000, China
  • Received:2023-12-21 Online:2024-08-15 Published:2024-08-21

Abstract: Objective To analyse the characteristics of adverse drug reaction/event(ADR/ADE) induced by Mailuo Shutong pills, so as to provide reference for clinical safe medication. Methods Five hundred and sixty cases of ADR/ADE reports involving Mailuo Shutong pills in Shandong Province Adverse Drug Reaction Monitoring System between 2004 and 2023 were analyzed in terms of the types of reports, categories of reporting institutions, annual changes, gender, age, systems-organs ADR/ADE involved, clinical manifestations, reasons for medication, combined medications and clinical outcomes. Results There were a total of 560 cases of ADR/ADE caused by Mailuo Shutong pills, 540 (96.43%) of which were normal ones, and 20 (3.57%) were severe ones. The main systems-organs involved in ADR/ADE were the gastrointestinal system, skin and its accessories, systemic reactions, and the central and peripheral nervous system. The clinical manifestations of ADR/ADE were mostly nausea, vomiting, diarrhea, itching and rash. In 471 of these cases (84.11%), ADR/ADE had no significant effect on the preexisting diseases, but 19 s (3.39%) refused to improve, and 70 (12.50%) lost contact. Conclusion The post-marketing safety of Mailuo Shutong pills is good, but there are occasionally serious adverse reactions. Clinicians need to be alert to potential risks to drug quality or medications.

Key words: Mailuo Shutong pills, adverse drug reactions/events (ADR/ADE), gastrointestinal, cutaneous, central nervous system, peripheral nervous system, safety

CLC Number: